PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(02): 169-174
DOI: 10.1055/s-0041-1735583
Original Article

A Microbiological Study of Acinetobacter calcoaceticus baumannii with Special Reference to Multidrug Resistance

Autor*innen

  • Langamba Angom Longjam 

    1   Department of Microbiology, Sikkim Manipal Institute of Medical Sciences, Gangtok, Sikkim, India

  • Dechen Chomu Tsering

    1   Department of Microbiology, Sikkim Manipal Institute of Medical Sciences, Gangtok, Sikkim, India

  • Dipmala Das

    2   Department of Microbiology, IQ City Medical College and Hospital, Durgapur, West Bengal, India
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Introduction The outbreak of Acinetobacter calcoaceticus baumannii (ACB) is mainly reported to be a notorious pathogens at health-care settings. It is the major problem on the health-care system with high morbidity and mortality rates because of the broad range of antibiotic resistance and lack of understanding the mechanism of developing new antibiotic resistance rapidly. It emphasizes the importance of local surveillance in describing or understanding and predicting microbial resistance patterns so that there will be limited use of antibiotics by developing strategies to control the extensive use of antimicrobial chemotherapy in clinical environment, which is still considered as one of the factors in the emergence of multidrug resistance microorganisms.

Objectives The study aims to detect the occurrence rate of ACB infections from various clinical samples, identify the resistance levels to different groups of antimicrobial agents, and the occurrence rate of multidrug resistant (MDR) ACB clinical isolates from a tertiary hospital in Durgapur, West Bengal, India.

Material and Methods The study was performed in the Department of Microbiology of the IQ City Medical College and Hospital, Durgapur, West Bengal, India, for the 24 months duration, that is, from January 1, 2018 to December 31, 2019. Altogether 15,800 clinical samples consisting of endotracheal tube aspirates, sputum, pus, blood, catheter tips, urine, tissue, and other body fluids were studied. ACB from clinical samples were identified by its characteristic colonies (nonlactose fermenting, glistening, small mucoid colonies), Gram-staining pattern (Gram-negative coccobacillus), and standard biochemical reactions. It was further confirmed in the Department of Microbiology of the Healthworld Hospital, Durgapur, West Bengal, India, by Vitek2 compact system (bioMerieux, Inc., Durham, North Carolina, United States). Antibiotic susceptibility testing was performed using automated broth microdilutions by Vitek2 compact system (bioMerieux, Inc.) and Kirby-Bauer disk diffusion test on Mueller-Hinton Agar (HiMedia).

Results Nonrepetitive 289 ACB were isolated from various clinical samples. A total of 277 (96%) isolates of ACB were MDR strains.

Conclusion ACB was mostly isolated from the intensive care unit department and was found to be the most MDR type in the tertiary care hospital by this study.

Keywords

Acinetobacter calcoaceticus baumannii - antibiotic susceptibility testing - MDR strains - Vitek2 compact system

Source(s) of Support

None.


Authors' Contributions

L.L.A.: Literature search, review of literature, manuscript preparation, concept and design of the study, data collection, statistically analyzed and interpreted, prepared first draft of manuscript, and critical review of study proposal.


D.C.T.: Scientific advisor, critical review of study proposal, and helped in preparing first draft of manuscript.


D.D.: Scientific advisor, critical review of study proposal, and data collection.




Publikationsverlauf

Artikel online veröffentlicht:
22. September 2021

© 2021. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India